Could the Combined Administration of Bone Antiresorptive Drug, Taxanes, and Corticosteroids Worsen Medication Related Osteonecrosis of the Jaws in Cancer Patients?

Giuseppina Campisi, Olga Di Fede, Giacomo Oteri, Antonia Marcianò, Antonio Picone, Riccardo Nucera, Ilaria Morreale, Vera Panzarella

Risultato della ricerca: Article

Abstract

The study presents a report of 58 metastatic cancer patients who developed osteonecrosis of the jaws after being treated with zoledronic acid and taxanes, plus corticosteroids. A retrospective analysis of data registered in the archives of two Italian osteonecrosis of the jaws treatment centers, who are based at the University of Messina and at the University of Palermo, was performed in order to study, in these patients, demographic data and characteristics such as frequency of cancer location, lines of therapy, frequency of cancer drugs, presence/absence of oral trigger, number, location, and stage of jaw osteonecrosis. It was found that the majority of patients developed advanced stages of osteonecrosis, frequently complicated with infection. It was hypothesized that the concurrent administration of chemotherapeutic agents could be eventually considered as a factor able to allow a faster worsening of the clinical manifestation through the exacerbation of soft tissue defects, due to chemotherapy drugs.
Lingua originaleEnglish
Numero di pagine0
RivistaDefault journal
Volume2018
Stato di pubblicazionePublished - 2018

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cita questo

Could the Combined Administration of Bone Antiresorptive Drug, Taxanes, and Corticosteroids Worsen Medication Related Osteonecrosis of the Jaws in Cancer Patients? / Campisi, Giuseppina; Di Fede, Olga; Oteri, Giacomo; Marcianò, Antonia; Picone, Antonio; Nucera, Riccardo; Morreale, Ilaria; Panzarella, Vera.

In: Default journal, Vol. 2018, 2018.

Risultato della ricerca: Article

Campisi, G, Di Fede, O, Oteri, G, Marcianò, A, Picone, A, Nucera, R, Morreale, I & Panzarella, V 2018, 'Could the Combined Administration of Bone Antiresorptive Drug, Taxanes, and Corticosteroids Worsen Medication Related Osteonecrosis of the Jaws in Cancer Patients?', Default journal, vol. 2018.
Campisi G, Di Fede O, Oteri G, Marcianò A, Picone A, Nucera R e altri. Could the Combined Administration of Bone Antiresorptive Drug, Taxanes, and Corticosteroids Worsen Medication Related Osteonecrosis of the Jaws in Cancer Patients? Default journal. 2018;2018.
Campisi, Giuseppina ; Di Fede, Olga ; Oteri, Giacomo ; Marcianò, Antonia ; Picone, Antonio ; Nucera, Riccardo ; Morreale, Ilaria ; Panzarella, Vera. / Could the Combined Administration of Bone Antiresorptive Drug, Taxanes, and Corticosteroids Worsen Medication Related Osteonecrosis of the Jaws in Cancer Patients?. In: Default journal. 2018 ; Vol. 2018.
@article{0dc99cfb2e13402ebe6fe017f241cf65,
title = "Could the Combined Administration of Bone Antiresorptive Drug, Taxanes, and Corticosteroids Worsen Medication Related Osteonecrosis of the Jaws in Cancer Patients?",
abstract = "The study presents a report of 58 metastatic cancer patients who developed osteonecrosis of the jaws after being treated with zoledronic acid and taxanes, plus corticosteroids. A retrospective analysis of data registered in the archives of two Italian osteonecrosis of the jaws treatment centers, who are based at the University of Messina and at the University of Palermo, was performed in order to study, in these patients, demographic data and characteristics such as frequency of cancer location, lines of therapy, frequency of cancer drugs, presence/absence of oral trigger, number, location, and stage of jaw osteonecrosis. It was found that the majority of patients developed advanced stages of osteonecrosis, frequently complicated with infection. It was hypothesized that the concurrent administration of chemotherapeutic agents could be eventually considered as a factor able to allow a faster worsening of the clinical manifestation through the exacerbation of soft tissue defects, due to chemotherapy drugs.",
author = "Giuseppina Campisi and {Di Fede}, Olga and Giacomo Oteri and Antonia Marcian{\`o} and Antonio Picone and Riccardo Nucera and Ilaria Morreale and Vera Panzarella",
year = "2018",
language = "English",
volume = "2018",
journal = "Default journal",

}

TY - JOUR

T1 - Could the Combined Administration of Bone Antiresorptive Drug, Taxanes, and Corticosteroids Worsen Medication Related Osteonecrosis of the Jaws in Cancer Patients?

AU - Campisi, Giuseppina

AU - Di Fede, Olga

AU - Oteri, Giacomo

AU - Marcianò, Antonia

AU - Picone, Antonio

AU - Nucera, Riccardo

AU - Morreale, Ilaria

AU - Panzarella, Vera

PY - 2018

Y1 - 2018

N2 - The study presents a report of 58 metastatic cancer patients who developed osteonecrosis of the jaws after being treated with zoledronic acid and taxanes, plus corticosteroids. A retrospective analysis of data registered in the archives of two Italian osteonecrosis of the jaws treatment centers, who are based at the University of Messina and at the University of Palermo, was performed in order to study, in these patients, demographic data and characteristics such as frequency of cancer location, lines of therapy, frequency of cancer drugs, presence/absence of oral trigger, number, location, and stage of jaw osteonecrosis. It was found that the majority of patients developed advanced stages of osteonecrosis, frequently complicated with infection. It was hypothesized that the concurrent administration of chemotherapeutic agents could be eventually considered as a factor able to allow a faster worsening of the clinical manifestation through the exacerbation of soft tissue defects, due to chemotherapy drugs.

AB - The study presents a report of 58 metastatic cancer patients who developed osteonecrosis of the jaws after being treated with zoledronic acid and taxanes, plus corticosteroids. A retrospective analysis of data registered in the archives of two Italian osteonecrosis of the jaws treatment centers, who are based at the University of Messina and at the University of Palermo, was performed in order to study, in these patients, demographic data and characteristics such as frequency of cancer location, lines of therapy, frequency of cancer drugs, presence/absence of oral trigger, number, location, and stage of jaw osteonecrosis. It was found that the majority of patients developed advanced stages of osteonecrosis, frequently complicated with infection. It was hypothesized that the concurrent administration of chemotherapeutic agents could be eventually considered as a factor able to allow a faster worsening of the clinical manifestation through the exacerbation of soft tissue defects, due to chemotherapy drugs.

UR - http://hdl.handle.net/10447/297290

UR - http://www.hindawi.com/journals/biomed/

M3 - Article

VL - 2018

JO - Default journal

JF - Default journal

ER -

Accesso al documento